All In MedTech

FDA Clearance Tracker · P040050-S001

MACROPLASTIQUE IMPLANTS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 27, 2007 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 27, 2007

Approved

Time to decision

147 days

Received Mar 2, 2007. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P040050-S001
Device name
MACROPLASTIQUE IMPLANTS
Applicant location
Minnetonka, MN
Received
Mar 2, 2007
Decided
Jul 27, 2007
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P040050

Device type

Device class
Class III

Every decision under product code LNM

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE CHANGE FROM MINNEAPOLIS, MINNESOTA TO MINNETONKA, MINNESOTA.

Source documents

Other decisions for Uroplasty, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.